T1	drug 0 8	Warfarin
T2	food 1004 1008	food
T3	parameter 104 123	Thrombo-test values
T4	mealTime 124 129	after
T5	food 130 135	natto
T6	mode 136 142	intake
T7	population 160 168	patients
T8	drugClass 180 201	anticoagulant therapy
T9	mealTime 202 207	after
T10	treatedDisease 208 236	valve replacement operations
T11	food 23 28	natto
T12	population 263 269	humans
T13	population 274 281	rabbits
T14	food 315 320	natto
T15	interaction 327 348	strongly antagonistic
T16	interaction 33 41	increase
T17	drug 352 360	warfarin
T18	component 388 402	Bacillus natto
T19	food 416 421	natto
T20	parameter 45 60	serum vitamin K
T21	parameter 454 488	vitamin K in the intestinal tracts
T22	mealTime 489 494	after
T23	interaction 526 536	antagonism
T24	food 540 545	natto
T25	drug 549 557	Warfarin
T26	parameter 593 602;620 632	vitamin K in the organ
T27	mode 64 70	intake
T28	parameter 661 680	vitamin K in plasma
T29	population 684 699	healthy persons
T30	mealTime 700 705	after
T31	mode 706 712	intake
T32	food 716 721	natto
T33	interaction 734 743	increases
T34	food 74 79	natto
T35	parameter 747 762	serum vitamin K
T36	drugClass 767 788	anticoagulant therapy
T37	parameter 821 829	TT value
T38	interaction 9 19	antagonism
T39	interaction 95 103	elevated
T40	drug 955 963	Warfarin
A1	valence T16 Augmentation
A2	valence T39 Augmentation
A3	valence T33 Augmentation
R1	physiological_effect_antagonism Arg1:T14 Arg2:T17	
R2	physiological_effect_antagonism Arg1:T24 Arg2:T25	
R3	physiological_effect_antagonism Arg1:T5 Arg2:T8	
R4	physiological_effect_antagonism Arg1:T11 Arg2:T1	
